tm logo
BT
Live/Registered
REGISTERED

on 16 Aug 2022

Last Applicant/ Owned by

555 Long Wharf Drive, 12th Floor

New Haven

CT

06516

Serial Number

88910081 filed on 11th May 2020

Registration Number

6821655 registered on 16th Aug 2022

in the Principal Register

Correspondent Address

Brendan J. Hughes

Brendan J. Hughes

1299 PENNSYLVANIA AVENUE, SUITE 7000

WASHINGTON DC 20004

Filing Basis

1. intent to use

2. use application currently

Disclaimer

NO DATA

BT

Pharmaceutical preparations in the field of immuno-oncology; pharmaceutical preparations for the treatment of neurological conditions Pharmaceutical research and development in the fields of neuroscience and immuno-oncology

Classification Information


Class [005]
Pharmaceutical Products


Pharmaceutical preparations in the field of immuno-oncology; pharmaceutical preparations for the treatment of neurological conditions


First Use Date in General

30th Apr 2017

First Use Date in Commerce

30th Apr 2017

Class [042]
Computer & Software Services & Scientific Services


Pharmaceutical research and development in the fields of neuroscience and immuno-oncology


First Use Date in General

30th Apr 2017

First Use Date in Commerce

30th Apr 2017

Mark Details


Serial Number

No 88910081

Mark Type

No Service Mark

Attorney Docket Number

No

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

No

66A Current

No

Current Basis

No

No Basis

No

Design Code(s)

26.17.09 -

Curved line(s), band(s) or bar(s)

27.03.01 -

Geometric figures forming letters or numerals, including punctuation

Legal History


Show more

Status DateAction Taken
16th Aug 2022NOTICE OF REGISTRATION CONFIRMATION EMAILED
16th Aug 2022REGISTERED-PRINCIPAL REGISTER
12th Jul 2022NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
11th Jul 2022ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
27th May 2022TEAS/EMAIL CORRESPONDENCE ENTERED
27th May 2022CORRESPONDENCE RECEIVED IN LAW OFFICE
27th May 2022TEAS RESPONSE TO OFFICE ACTION RECEIVED
31st Jan 2022NOTIFICATION OF NON-FINAL ACTION E-MAILED
31st Jan 2022NON-FINAL ACTION E-MAILED
31st Jan 2022SU - NON-FINAL ACTION - WRITTEN